arrow
Back
D

David H. Kirn

University of California System

73H-index
303Paper Count
2.2WCitation Count
Published Papers 70
Publication Date
Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies
err2024-12-02
err0
errOAAI
errCalton, Melissa A.; Croze, Roxanne H.; Burns, Christian; Beliakoff, Ghezal; Vazin, Tandis; Szymanski, Paul; Schmitt, Christopher; Klein, Austin; Leong, Meredith; Quezada, Melissa; Holt, Jenny; Bolender, Gabe; Barglow, Katherine; Khoday, Devi; Mason, Thomas; Delaria, Katherine; Hassanipour, Mohammad; Kotterman, Melissa; Khanani, Arshad M.; Schaffer, David; Francis, Peter; Kirn, David
errShare
errSave
Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies
err2024-01-02
err26
errOAAI
errSalabarria, Stephanie M.; Corti, Manuela; Coleman, Kirsten E.; Wichman, Megan B.; Berthy, Julie A.; D'Souza, Precilla; Tifft, Cynthia J.; Herzog, Roland W.; Elder, Melissa E.; Shoemaker, Lawrence R.; Leon-Astudillo, Carmen; Tavakkoli, Fatemeh; Kirn, David H.; Schwartz, Jonathan D.; Byrne, Barry J.
errShare
errSave
Cardiac effects of 4D-310 in adults with Fabry disease in a phase 1/2 clinical trial: Functional, quality of life, and imaging endpoints in patients with 12 months of follow up
err2023-02-01
err3
PREAI
errSchiffmann, Raphael; Goker-Alpan, Ozlem; Vockley, Jerry; Wilcox, William R.; Ortiz, Damara; Nie, Molly; Shen, Jinsong; Tavakkoli, Fatemeh; Kirn, David; Fishman, Robert
errShare
errSave
An open-label, phase 1/2 trial of gene therapy 4D-310 in adult males with Fabry disease
err2022-02-01
err0
PREAI
errVockley, Jerry; Wilcox, William R.; Goker-Alpan, Ozlem; Nie, Molly; Shen, Jinsong; Kirn, David; Fishman, Robert S.; Schiffmann, Raphael
errShare
errSave
Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing
err2021-05-27
err11
errOAAI
errInoue, Tomoyoshi; Byrne, Thomas; Inoue, Mitsuko; Tait, Madeline E.; Wall, Patrick; Wang, Annabel; Dermyer, Michael R.; Laklai, Hanane; Binder, Joseph J.; Lees, Clare; Hollingsworth, Robert; Maruri-Avidal, Liliana; Kirn, David H.; McDonald, Donald M.
errShare
errSave
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
err2019-06-03
err94
errOAAI
errMoehler, M.; Heo, J.; Lee, H. C.; Tak, W. Y.; Chao, Y.; Paik, S. W.; Yim, H. J.; Byun, K. S.; Baron, A.; Ungerechts, G.; Jonker, D.; Ruo, L.; Cho, M.; Kaubisch, A.; Wege, H.; Merle, P.; Ebert, O.; Habersetzer, F.; Blanc, J. F.; Rosmorduc, Olivier; Lencioni, R.; Patt, R.; Leen, A. M.; Foerster, F.; Homerin, M.; Stojkowitz, N.; Lusky, M.; Limacher, J. M.; Hennequi, M.; Gaspar, N.; McFadden, B.; De Silva, N.; Shen, D.; Pelusio, A.; Kirn, D. H.; Breitbach, C. J.; Burke, J. M.
errShare
errSave
Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms
err2018-02-14
err52
errOAAI
errKim, Minah; Nitschke, Maximilian; Sennino, Barbara; Murer, Patrizia; Schriver, Brian J.; Bell, Alexander; Subramanian, Aishwarya; McDonald, Corry E.; Wang, Jiahu; Cha, Howard; Bourgeois-Daigneault, Marie-Claude; Kirn, David H.; Bell, John C.; De Silva, Naomi; Breitbach, Caroline J.; McDonald, Donald M.
errShare
errSave
Intratumoral injection of the oncolytic immunotherapeutic Pexa-Vec (JX-594) in liver tumors and hepatocellular carcinoma: Recommendations for clinical practice
err2015-09-01
err1
PREAI
errLencioni, R.; Kim, C. W.; Rose, S. C.; Breitbach, C. J.; Burke, J. M.; Hickman, T.; Kirn, D. H.; Stojkowitz, N.; Lusky, M.; Homerin, M.
errShare
errSave
Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer
err2015-09-01
err154
errOAAI
errPark, Se Hoon; Breitbach, Caroline J.; Lee, Jeeyun; Park, Joon Oh; Lim, Ho Yeong; Kang, Won Ki; Moon, Anne; Mun, Jae-Hee; Sommermann, Erica M.; Avidal, Liliana Maruri; Patt, Rick; Pelusio, Adina; Burke, James; Hwang, Tae-Ho; Kirn, David; Park, Young Suk
errShare
errSave
Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic
err2015-08-01
err43
PREAI
errBreitbach, Caroline J.; Parato, Kelley; Burke, James; Hwang, Tae-Ho; Bell, John C.; Kirn, David H.
errShare
errSave
Synergistic actions of oncolytic vaccinia virus and sunitinib on pancreatic neuroendocrine tumors in RIP-Tag2 mice
err2015-08-01
err0
PREAI
errMcDonald, Corry E.; Sennino, Barbara; Schriver, Brian J.; Bell, John C.; Kirn, David H.; Breitbach, Caroline J.; McDonald, Donald M.
errShare
errSave
Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus Macaques
err2015-06-01
err63
errOAAI
errEvgin, Laura; Acuna, Sergio A.; de Souza, Christiano Tanese; Marguerie, Monique; Lemay, Chantal G.; Ilkow, Carolina S.; Findlay, C. Scott; Falls, Theresa; Parato, Kelley A.; Hanwell, David; Goldstein, Alyssa; Lopez, Roberto; Lafrance, Sandra; Breitbach, Caroline J.; Kirn, David; Atkins, Harold; Auer, Rebecca C.; Thurman, Joshua M.; Stahl, Gregory L.; Lambris, John D.; Bell, John C.; McCart, J. Andrea
errShare
errSave
Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients
err2015-03-01
err141
errOAAI
errCripe, Timothy P.; Ngo, Minhtran C.; Geller, James I.; Louis, Chrystal U.; Currier, Mark A.; Racadio, John M.; Towbin, Alexander J.; Rooney, Cliona M.; Pelusio, Adina; Moon, Anne; Hwang, Tae-Ho; Burke, James M.; Bell, John C.; Kirn, David H.; Breitbach, Caroline J.
errShare
errSave
First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity
err2015-01-01
err140
errOAAI
errZeh, Herbert J.; Downs-Canner, Stephanie; McCart, J. Andrea; Guo, Zong Sheng; Rao, Uma N. M.; Ramalingam, Lekshmi; Thorne, Stephen H.; Jones, Heather L.; Kalinski, Pawel; Wieckowski, Eva; O'Malley, Mark E.; Daneshmand, Manijeh; Hu, Kang; Bell, John C.; Hwang, Tae-Ho; Moon, Anne; Breitbach, Caroline J.; Kirn, David H.; Bartlett, David L.
errShare
errSave
Oncolytic and Immunotherapeutic Vaccinia Induces Antibody-Mediated Complement-Dependent Cancer Cell Lysis in Humans
err2013-05-15
err98
PREAI
errKim, Mi Kyung; Breitbach, Caroline J.; Moon, Anne; Heo, Jeong; Lee, Yu Kyoung; Cho, Mong; Lee, Jun Woo; Kim, Seong-Geun; Kang, Dae Hwan; Bell, John C.; Park, Byeong Ho; Kirn, David H.; Hwang, Tae-Ho
errShare
errSave
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
err2013-02-14
err221
errOAAI
errBreitbach, Caroline J.; Arulanandam, Rozanne; De Silva, Naomi; Thorne, Steve H.; Patt, Richard; Daneshmand, Manijeh; Moon, Anne; Ilkow, Carolina; Burke, James; Hwang, Tae-Ho; Heo, Jeong; Cho, Mong; Chen, Hannah; Angarita, Fernando A.; Addison, Christina; McCart, J. Andrea; Bell, John C.; Kirn, David H.
errShare
errSave
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
err2013-02-10
err688
errOAAI
errHeo, Jeong; Reid, Tony; Ruo, Leyo; Breitbach, Caroline J.; Rose, Steven; Bloomston, Mark; Cho, Mong; Lim, Ho Yeong; Chung, Hyun Cheol; Kim, Chang Won; Burke, James; Lencioni, Riccardo; Hickman, Theresa; Moon, Anne; Lee, Yeon Sook; Kim, Mi Kyeong; Daneshmand, Manijeh; Dubois, Kara; Longpre, Lara; Ngo, Minhtran; Rooney, Cliona; Bell, John C.; Rhee, Byung-Geon; Patt, Richard; Hwang, Tae-Ho; Kirn, David H.
errShare
errSave
The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
err2012-04-01
err233
errOAAI
errParato, Kelley A.; Breitbach, Caroline J.; Le Boeuf, Fabrice; Wang, Jiahu; Storbeck, Chris; Ilkow, Carolina; Diallo, Jean-Simon; Falls, Theresa; Burns, Joseph; Garcia, Vanessa; Kanji, Femina; Evgin, Laura; Hu, Kang; Paradis, Francois; Knowles, Shane; Hwang, Tae-Ho; Vanderhyden, Barbara C.; Auer, Rebecca; Kirn, David H.; Bell, John C.
errShare
errSave